teprotide has been researched along with Neuroblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Himeno, E; Iinuma, KM; Kira, J; Ma, L; Miyoshi, K; Nakamura, N; Ohyagi, Y; Sakae, N; Soejima, N; Yamasaki, R; Yanagihara, YT | 1 |
| Gafni, M; Keren, O; Sarne, Y; Shapira, M | 1 |
2 other study(ies) available for teprotide and Neuroblastoma
| Article | Year |
|---|---|
Activation of glutathione peroxidase and inhibition of p53-related apoptosis by apomorphine.
Topics: Apomorphine; Apoptosis; Catalase; Cell Line, Tumor; Cell Survival; Death Domain Receptor Signaling Adaptor Proteins; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression Regulation; Glutathione; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Glutathione Reductase; Humans; Hydrogen Peroxide; Neuroblastoma; Oxidative Stress; Teprotide | 2011 |
Divers pathways mediate delta-opioid receptor down regulation within the same cell.
Topics: Acetylcysteine; Analgesics, Opioid; Animals; Antirheumatic Agents; Chloroquine; Cysteine Proteinase Inhibitors; Diprenorphine; Down-Regulation; Etorphine; Flavonoids; Genistein; GTP-Binding Proteins; Humans; Kidney; MAP Kinase Signaling System; Narcotic Antagonists; Neuroblastoma; Phosphorylation; Radioligand Assay; Receptors, Opioid, delta; Staurosporine; Teprotide; Transfection; Tritium; Tumor Cells, Cultured | 2001 |